REG - Nuformix PLC - Director/PDMR Shareholding

NuformixAnnouncement

16/09/2021 12:50

RNS Number : 0420M
  
Nuformix PLC
  
16 September 2021
  
 

16 September 2021 
Nuformix plc
 
("Nuformix" or the "the Company")
  
Director/PDMR Shareholding
 
Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, announces that today the Company received notice that Dr Alastair Riddell, Chairman of the Company, purchased 350,000 ordinary shares of 0.1 pence each ("Ordinary Shares") at a price of 0.0135 pence per share on 16 September 2021.
 
- Ends -
 
 Enquiries:



 Nuformix plc


+44 (0) 1223 627 222




Dr Anne Brindley, CEO


















Allenby Capital Limited


+44 (0) 20 3328 5656




Nick Athanas / George Payne (Corporate Finance)








Stefano Aquilino / Matt Butlin (Sales & Corporate Broking)


















Walbrook PR
Anna Dunphy / Paul McManus


+44 (0) 20 7933 8780
nuformix@walbrookpr.com



 
 
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
 
 



1 
 


Details of the person discharging managerial responsibilities / person closely associated 
 




a) 
 


Name 
 


Dr Alastair Riddell




2 
 


Reason for the notification 
 




a) 
 


Position/status 
 


PDMR - Chairman




b) 
 


Initial notification /Amendment 
 


Initial notification




3 
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
 




a) 
 


Name 
 


Nuformix plc




b) 
 


LEI 
 


2138003XG3H3I2J3BJ24




4 
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 




a) 
 


Description of the financial instrument, type of instrument 
 
Identification code 
 


Ordinary Shares of nominal value 0.1 pence each 
 
 
GB00BYW79Y38




b) 
 


Nature of the transaction 
 


Purchase of Ordinary Shares 




c) 
 


Price(s) and volume(s) 
 
 





Price(s)
 


Volume(s)




0.0135p
 


350,000
 








d) 
 


Aggregated information 
 
- Aggregated volume 
 
- Price 
 
- Total


 
 
350,000
 
0.0135p
 
£4,725.00




e) 
 


Date of the transaction 
 


16 September 2021




f) 
 


Place of the transaction 
 


London Stock Exchange, Main Market



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHGPUACBUPGGGQ